Refining prognosis and identifying targetable pathways for high-risk endometrial cancer: a TransPORTEC initiative.

Cited by (491)

Items 201–300 of 491

1. Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
   Anna Schuh, Helene Marie-Pierre Dreau, Samantha J.L. Knight, Kate E. Ridout, Tuba Mizani, Dimitris V. Vavoulis, Richard T. Colling, Pavlos Antoniou, Erika M. Kvikstad, Melissa M. Pentony et al. · 2018 · Molecular Case Studies
2. Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort
   Changmin Yu, Xin‐hui Yuan, Qianlan Yao, Yuyin Xu, Xiaoyan Zhou, Xin Hu, Huijuan Yang, Huaying Wang, Xiaoli Zhu, Ren Yulan · 2024 · BMC Cancer
3. The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
   Qing Wu, Nianhai Zhang, Xianhe Xie · 2022 · BMC Cancer
4. Molecular typing guiding treatment and prognosis of endometrial cancer
   Junya Tabata, Masataka Takenaka, Aikou Okamoto · 2023 · Gynecology and Obstetrics Clinical Medicine
5. The Role of FBXW7 in Gynecologic Malignancies
   Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, Yashwanth Subbannayya, Sarah Suleiman, Mariela Vasileva‐Slaveva, Angel Danchev Yordanov, Francesca Pentimalli, Antonio Giordano, Jean Calleja‐Agius · 2023 · Cells
6. Harmonized molecular classification; assessment of a single-test ProMisE NGS tool
   Amy Jamieson, Melissa K. McConechy, Amy M. Lum, Samuel C. Y. Leung, Emily F. Thompson, Janine Senz, Aline Talhouk, David D. Huntsman, Ali Bashashati, C. Blake Gilks et al. · 2023 · Gynecologic Oncology
7. FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes
   Asmerom Tesfamariam Sengal, Ann‐Marie Patch, Cameron Edward Snell, Deborah S. Smith, Samuel C. Y. Leung, Aline Talhouk, Elizabeth D. Williams, Jessica Nell McAlpine, Pamela M. Pollock · 2020 · Clinical Cancer Research
8. Molecular Profiles of Mixed Endometrial Carcinoma
   Cathleen E. Matrai, Samaneh A Motanagh, Susanna Mirabelli, Lucy X Ma, Bing He, Eloise Chapman‐Davis, Boaz Kurtis, Olivier Elemento, Juan Miguel Mosquera, Lora H. Ellenson · 2020 · The American Journal of Surgical Pathology
9. The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy?
   Mohamed Laban, Seif Tarek El‐Swaify, S.H. Ali, Mazen A. Refaat, Mohamed Sabbour, Nourhan Farrag, Alaa Sayed Hassanin · 2021 · Reproductive Sciences
10. Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer
    Junhwan Kim, Se Ik Kim, Nae Ry Kim, Hyojin Kim, Hee Seung Kim, Hyun Hoon Chung, Jae‐Weon Kim, Cheol Min Lee, Maria Lee · 2023 · Gynecologic Oncology
11. Adjuvant therapy in stage III endometrial cancer confined to the pelvis
    Reem Albeesh, Guy‐Anne Turgeon, Joanne Alfieri, José João Mansure, Lili Fu, Jocelyne Arseneau, Xing Ziggy Zeng, Kris Jardon, Lucy Gilbert, Luís Souhami · 2018 · Gynecologic Oncology
12. Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis
    Antonio Travaglino, Antonio Raffone, Annarita Gencarelli, Serena Saracinelli, Carla Riccardi, Antonio Mollo, Fulvio Zullo, Luigi Insabato · 2020 · Gynecologic Oncology
13. Automated causal inference in application to randomized controlled clinical trials
    Jiqing Wu, Nanda Horeweg, Marco de Bruyn, Remi A. Nout, Ina Maria Jurgenliemk-Schulz, Ludy C.H.W. Lutgens, Jan J. Jobsen, Elzbieta M. van der Steen‐Banasik, Hans W. Nijman, Vincent T.H.B.M. Smit et al. · 2022 · Nature Machine Intelligence
14. Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
    Manouk van Esterik, Inge C. van Gool, Cor Doede de Kroon, Remi A. Nout, Carien L. Creutzberg, Vincent T.H.B.M. Smit, Tjalling Bosse, Ellen Stelloo · 2017 · Oncotarget
15. Classification histologique et moléculaire des cancers de l’endomètre et leurs implications dans la thérapeutique
    Catherine Genestie, Alexandra F. Leary, Mojgan Devouassoux‐Shisheboran, Aurélie Auguste · 2017 · Bulletin du Cancer
16. Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment
    Camilla Nero, Francesca Ciccarone, Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Giovanni Scambia, Domenica Lorusso · 2021 · Frontiers in Oncology
17. Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer
    Luka Roškar, Irena Roškar, Tea Lanišnik Rižner, Špela Smrkolj · 2021 · Biomolecules
18. Obesity and endometrial cancer: unanswered epidemiological questions
    Andrew G. Renehan, Michelle Louise MacKintosh, Emma Jayne Crosbie · 2015 · BJOG An International Journal of Obstetrics & Gynaecology
19. Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
    Kristina Yvonne Lindemann, Elisabeth Smogeli, Milada Cvancarova Småstuen, Kjersti Bruheim, Jone Trovik, Terje Nordberg, Gunnar Balle Kristensen, Henrica M.J. Werner, Esten Søndrol Nakken · 2021 · Cancers
20. Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma: Implications for Clinical HER2 Testing and Interpretation
    Natália Buza, Pei Hui · 2022 · Archives of Pathology & Laboratory Medicine
21. Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Sarah A. Ackroyd, David Arguello, Pilar Ramos, Haider Mahdi, Adam C. ElNaggar, Ira Seth Winer, Robert W. Holloway, Thomas C. Krivak, Nathaniel Jones, Valerie Bianca Galvan-Turner et al. · 2022 · Gynecologic Oncology
22. Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis
    Antonio Travaglino, Damiano Arciuolo, Angela Santoro, Antonio Raffone, Luigi Pedone Anchora, Alessia Piermattei, Manuela Martinelli, Antonio Mollo, Maria Elisabetta Onori, Angelo Minucci et al. · 2022 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
23. New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere
    Ilan Bruchim, Ilaria Capasso, Ariel Polonsky, Shilhav Meisel, Vanda Salutari, Haim Werner, Domenica Lorusso, Giovanni Scambia, Francesco Fanfani · 2024 · Expert Opinion on Therapeutic Targets
24. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis
    Shi Guo, Jie Yang, Man Wu, Guohong Xiao · 2019 · Pathology - Research and Practice
25. Cancer predisposition syndromes: lessons for truly precision medicine
    Mark A. Glaire, Matthew Brown, David N. Church, Ian P.M. Tomlinson · 2016 · The Journal of Pathology
26. High‐risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels
    Mary Ellen Urick, Eun‐Jeong Yu, Daphne W. Bell · 2021 · Cancer
27. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
    Merve Kaya, Cathalijne Post, Carli M.J. Tops, Maartje Nielsen, Emma Jayne Crosbie, Alexandra F. Leary, Linda Mileshkin, Kathy Chai-Zung Han, Paul Bessette, Stephanie M. de Boer et al. · 2024 · Modern Pathology
28. Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer
    Ana Luzarraga Aznar, Vicente Bebia, Carlos López-Gil, Beatriz Villafranca-Magdalena, Lourdes Salazar-Huayna, Josep Castellví, Eva Colás, Antonio Gil‐Moreno, Sílvia Cabrera · 2024 · International Journal of Gynecological Cancer
29. Prognostic performance of FIGO 2023 endometrial carcinoma staging: a comparison to FIGO 2009 staging in the setting of known and unknown molecular classification
    Diane M. Libert, Phoebe M. Hammer, Caressa Hui, Elizabeth A. Kidd, Ann Katherine Folkins, Teri A. Longacre, Eric Yang, Vivek Charu, Brooke E. Howitt · 2024 · Histopathology
30. Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer
    Ya He, Tian Wang, Na Li, Binkai Yang, Yuanjing Hu · 2020 · Medicine
31. Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas
    Nana P. Matsumoto, Padmini A. Manrai, Douglas A. Rottmann, Xinyu Wu, Hisham Assem, Pei Hui, Natália Buza · 2022 · International Journal of Gynecological Pathology
32. Adiponectin, Leptin, and Insulin-Pathway Receptors as Endometrial Cancer Subtyping Markers
    Evan L. Busch, Marta Crous‐Bou, Jennifer Prescott, Michael J. Downing, BERNARD A. ROSNER, George L. Mutter, Immaculata De Vivo · 2018 · Hormones and Cancer
33. Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis
    Clarissa J. Lam, Qin C Zhou, Carol A Aghajanian, Nadeem R. Abu‐Rustum, Jennifer Jean Mueller, Lora H. Ellenson, Angela K. Green, Britta Weigelt, Achim A. Jungbluth, Amir Momeni Boroujeni · 2025 · Gynecologic Oncology
34. DNA mismatch repair deficiency and p53 abnormality are age-related events in mixed endometrial carcinoma with a clear cell component
    Naoyuki Ida, Keiichiro Nakamura, Masayuki Saijo, Atsuko Nasu, Tadashi Yoshino, Hisashi Masuyama, Hiroyuki Yanai · 2021 · Pathology - Research and Practice
35. Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer Center
    Anna Plotkin, Ekaterina Olkhov‐Mitsel, Weei‐Yuarn Huang, Sharon Nofech‐Mozes · 2024 · Cancers
36. Estrogen induces cell proliferation by promoting ABCG2-mediated efflux in endometrial cancer cells
    Takahiro Yaguchi, Takafumi Onishi · 2018 · Biochemistry and Biophysics Reports
37. Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions
    Stephanie M. de Boer, Remi A. Nout, Tjalling Bosse, Carien L. Creutzberg · 2018 · Expert Review of Anticancer Therapy
38. Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma
    Yuan Li, Jiaqi Li, Ensong Guo, Jia Ming Huang, Guangguang Fang, Shaohua Chen, Bin Yang, Yu Fu, Fuxia Li, Zizhuo Wang et al. · 2020 · Cell & Bioscience
39. Glycosylation and its research progress in endometrial cancer
    Congli Pu, Biyuan, Kai Lin Xu, Yingchao Zhao · 2022 · Clinical & Translational Oncology
40. Immunologic Signatures across Molecular Subtypes and Potential Biomarkers for Sub-Stratification in Endometrial Cancer
    Fang Jiang, Shiyang Jiang, Dongyan Cao, Mingyi Mao, Yang Xiang · 2023 · International Journal of Molecular Sciences
41. In vitro effects of FBXW7 mutation in serous endometrial cancer: Increased levels of potentially druggable proteins and sensitivity to SI‐2 and dinaciclib
    Mary Ellen Urick, Daphne W. Bell · 2018 · Molecular Carcinogenesis
42. High-Grade Endometrial Carcinomas
    Joseph W. Carlson, Denis Nastic · 2019 · Surgical pathology clinics
43. The more tumors change, the more they stay tame: Do T cells keep POLE ultramutated endometrial carcinomas in check?
    Brad H. Nelson, Jessica Nell McAlpine · 2015 · Gynecologic Oncology
44. Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components
    Phoebe M. Hammer, Aihui Wang, Lisa Vermij, Sabrina Zdravkovic, Lucas Miecho Heilbroner, Emily Elizabeth Ryan, Rachel L P Geisick, Vivek Charu, Teri A. Longacre, Carlos Jose Suarez et al. · 2024 · The American Journal of Surgical Pathology
45. Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid
    Kelechi Njoku, Davide Chiasserini, Bethany Geary, Andrew Pierce, Eleanor R Jones, Anthony David Whetton, Emma Jayne Crosbie · 2021 · Cancers
46. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas
    Minhua Wang, Pei Hui · 2021 · Archives of Pathology & Laboratory Medicine
47. Pharmacological Treatment of Advanced, Persistent or Metastatic Endometrial Cancer: State of the Art and Perspectives of Clinical Research for the Special Issue “Diagnosis and Management of Endometrial Cancer”
    Angiolo Gadducci, Stefania Cosio · 2021 · Cancers
48. Further refining 2020 ESGO / ESTRO / ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis
    Camilla Nero, Tina Pasciuto, Serena Cappuccio, Giacomo Corrado, Silvia Pelligra, Gian Franco Zannoni, Angela Santoro, Alessia Piermattei, Angelo Minucci, Domenica Lorusso et al. · 2022 · Cancer
49. A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers
    Yang Li, Junnan Feng, Chengzhi Zhao, Meng Lin, Shanshan Shi, Kangdong Liu, Jie Ma · 2022 · Annals of Translational Medicine
50. One‐stop molecular classification of endometrial carcinoma using comprehensive next‐generation sequencing
    Yucong Li, Rui Chen, Mingming Yuan, Dong Wang, Chunling Fu, Rongrong Chen, Cuirong Lei, Qi Zhou · 2022 · International Journal of Cancer
51. Histone Modifying Enzymes in Gynaecological Cancers
    Priya Ramarao-Milne, Olga Kondrashova, Sinead C. Barry, John David Hooper, Jason S. Lee, Nicola Waddell · 2021 · Cancers
52. Precision medicine in endometrial cancer
    Jessica Nell McAlpine, C. Blake Gilks · 2019 · Gynecologic Oncology
53. Integrating Multi-Omics in Endometrial Cancer: From Molecular Insights to Clinical Applications
    Hye Kyeong Kim, Tae Jin Kim · 2025 · Cells
54. Molecular Characterization and Clinical Implications of Endometrial Cancer
    Angeles Alvarez Secord, Matthew A. Powell, Jessica Nell McAlpine · 2025 · Obstetrics and Gynecology
55. Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer
    Hye-Yeon Ju, Sung Min Yoon, Jun Kyu Kang, Soo Young Hur, Se-Jin Kim, Youn Jin Choi, Mi-Ryung Han · 2022 · Cancers
56. L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma
    Chiara Romani, Davide Capoferri, Casper Reijnen, Silvia Lonardi, Antonella Ravaggi, Martina Ratti, Mattia Bugatti, Laura Zanotti, Germana Tognon, Enrico Sartori et al. · 2022 · International Journal of Cancer
57. Histotype and Grade Are of Prognostic Significance in the No Specific Molecular Profile Molecular Subtype of Endometrial Carcinoma But Not in POLEmut, MMRd, or p53abn Endometrial Carcinomas: Results From a 2478 Case Series and a Systematic Review of the Literature
    Jutta K. Huvila, Aline Talhouk, C. Blake Gilks, Jessica Nell McAlpine, Amy Jamieson · 2025 · International Journal of Gynecological Pathology
58. Moving into the modern era of molecular classification for endometrial cancer
    Christian Dagher, Ying L. Liu, Jennifer Jean Mueller, Britta Weigelt · 2023 · Journal of Surgical Oncology
59. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing
    Kianoosh Keyhanian, Lucy M. Han, Brooke E. Howitt, Teri A. Longacre · 2023 · The American Journal of Surgical Pathology
60. Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer
    Zhansheng Jiang, Mingyu Zhu, Lu Zhang, Haiyan Cui, Richeng Jiang, Yanfang Yang, Richeng Jiang, Yanfang Yang · 2024 · Gynecologic Oncology
61. POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma
    Yiran Li, Qizhi He, Shuangdi Li, Xiaoli Wen, Lei Ye, Kai Wang, Xiaoping Wan · 2020 · OncoTargets and Therapy
62. Adjuvant Therapy for High-risk Endometrial Carcinoma
    Jananie Perera, Peter Hoskin · 2021 · Clinical Oncology
63. Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma
    Antonio Travaglino, Antonio Raffone, Damiano Arciuolo, Angela Santoro, Frediano Socrate Inzani, Anna Di Maio, Umberto Visiello, Caterina Fulgione, Maurizio Guida, Antonio Mollo et al. · 2022 · Pathology - Research and Practice
64. Molecular classification of endometrial cancer: entering an era of precision medicine
    Alison Goulder, Stephanie L. Gaillard · 2022 · Journal of Gynecologic Oncology
65. p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a Prognosis Indistinguishable From Serous Carcinoma
    Elmira Vaziri Fard, Sara Imboden, Tilman T. Rau, E. Epstein, Tirzah Braz Petta Lajus, Saloni Walia, Joseph W. Carlson · 2024 · International Journal of Gynecological Pathology
66. Identification of molecular subtypes for endometrial carcinoma using a 46-gene next-generation sequencing panel: a retrospective study on a consecutive cohort
    Q. Guo, S. Tang, Xingzhu Ju, Zhe Feng, Zhiyuan Zhang, D. Peng, Fang Liu, Huimin Du, J. Wang, Yuji Zhang et al. · 2024 · ESMO Open
67. Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifier
    Amy Jamieson, Marcel Philip Grube, Felix K. F. Kommoss, Amy M. Lum, Samuel C. Y. Leung, Derek S. Chiu, Gabriel Henderson, Florian Heitz, Sabine Heublein, A.G. Zeimet et al. · 2024 · International Journal of Gynecological Cancer
68. Interpretable Machine Learning for Proteomics‐Based Subtyping and Tumor Mutational Burden Prediction in Endometrial Cancer
    Thi‐My‐Trang Luong, Xuan‐Thanh Bui, Chii‐Ruey Tzeng, Nguyen Quoc Khanh Le · 2025 · PROTEOMICS - CLINICAL APPLICATIONS
69. Reducing Overtreatment in Gynecologic Oncology: The Case for Less in Endometrial and Ovarian Cancer
    Sarah Madhu Temkin, Edward J. Tanner, Summer B. Dewdney, Lori M. Minasian · 2016 · Frontiers in Oncology
70. Tumor Molecular Features Predict Endometrial Cancer Patients’ Survival After Open or Minimally Invasive Surgeries
    Yibo Dai, Jingyuan Wang, Luyang Zhao, Zhiqi Wang, Jianliu Wang · 2021 · Frontiers in Oncology
71. Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods
    Denizhan Bayramoğlu, Özlem Seçilmiş Kerimoğlu, Zeynep Bayramoğlu, Ersin Çintesun, Gözde Şahin, Pınar Karabağli, Çetın Çelık · 2022 · Ginekologia Polska
72. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
    Paul S. Weisman, Kay J. Park, Jin Yan Xu · 2022 · PubMed
73. Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience
    Valentina Tuninetti, Luca Pace, Eleonora Ghisoni, Virginia Quarà, Francesca Arezzo, Andrea Palicelli, Vincenzo Dario Mandato, Elena Geuna, Gennaro Cormio, Nicoletta Biglia et al. · 2023 · Cancers
74. Mixed Endometrial Epithelial Carcinoma: Epidemiology, Treatment and Survival Rates—A 10-Year Retrospective Cohort Study from a Single Institution
    Christina Pappa, Valentina Le Thanh, Sarah Louise Smyth, Andreas Zouridis, Ammara Kashif, Negin Sadeghi, Alisha Sattar, Stephen Damato, Mostafa Abdalla, Antonio Simone Laganà et al. · 2023 · Journal of Clinical Medicine
75. High-resolution copy number analysis of clear cell endometrial carcinoma
    Andrea J. O’Hara, Matthieu Le Gallo, Meghan L. Rudd, Daphne W. Bell · 2019 · Cancer Genetics
76. Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
    Francesca Malentacchi, Irene Turrini, Flavia Sorbi, Elisabetta Projetto, Francesca Castiglione, Federica Vergoni, Gianni Amunni, Massimiliano Fambrini, Felice Petraglia, Ivo Noci et al. · 2020 · Reproductive Sciences
77. Endometrial Cancer
    Joshua Jing Xi Li, Philip P.C. Ip · 2022 · Surgical pathology clinics
78. Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours
    Austin J. McHenry, Kelly A. Devereaux, Emily Elizabeth Ryan, Stephanie Ka-Yee Chow, Grace M. Allard, Chandler C. Ho, Carlos Jose Suarez, Ann Katherine Folkins, Eric Yang, Teri A. Longacre et al. · 2024 · Histopathology
79. Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomas
    Diocésio Alves Pinto de Andrade, Murilo Bonatelli, Flávia Escremim de Paula, Gustavo Nóriz Berardinelli, Gustavo Ramos Teixeira, Monise Tadin Reis, Flávia Fazzio Barbin, Carlos Eduardo Mattos da Cunha Andrade, Vinicius Pereira Aguiar, Alejandro Delfos Hermoza et al. · 2024 · Frontiers in Oncology
80. Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma
    Chae Young Shin, Bengul Gokbayrak, Valerie Lan Tao, Noorah Almadani, Eunice Li, Rebecca Ho, Felix K. F. Kommoss, Jutta K. Huvila, Derek S. Chiu, Samuel C. Y. Leung et al. · 2025 · Histopathology
81. Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining
    Hege Fredriksen Berg, Jone Trovik, Marta Espevold Hjelmeland, Hilde Eide Lien, Mari K. Halle, Ingfrid S. Haldorsen, Kathrine Woie, Camilla Krakstad · 2025 · Gynecologic Oncology
82. Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence
    Cathleen E. Matrai, Kentaro Ohara, Kenneth Eng, Shannon M. Glynn, Pooja Chandra, Sudeshna Chatterjee‐Paer, Samaneh A Motanagh, Susanna Mirabelli, Boaz Kurtis, Bing He et al. · 2021 · International Journal of Gynecological Pathology
83. Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
    Jorge Luis Ramón-Patiño, Ignacio Ruz‐Caracuel, Victoria Heredia-Soto, L.E. García de la Calle, Bulat Zagidullin, Yinyin Wang, Alberto Berjón, Álvaro López‐Janeiro, Maria Paz De Miguel, Javier Escudero et al. · 2022 · Cancers
84. HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review
    Valerio Mais, Maria Luisa Fais, Michele Peiretti, Daniela Fanni, Elena Massa, Giulia Carboni, Giuseppina Fais, Giuseppe Deo, Stefano L. Angioni · 2022 · Current Oncology
85. Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis
    Emanuele Perrone, Ilaria Capasso, Diana Giannarelli, Rita Trozzi, Luigi Congedo, Elisa Ervas, Vincenzo Tarantino, Giovanni Esposito, Luca Palmieri, Arianna Guaita et al. · 2024 · Gynecologic Oncology
86. The brave new world of endometrial cancer
    Simone Marnitz, Till Waltar, Christhardt Köhler, Alexander Mustea, Birgid Schömig‐Markiefka · 2020 · Strahlentherapie und Onkologie
87. Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
    Hongmei Ding, Fei Jiang, Lifeng Deng, Juan Wang, Ping Wang, Mintao Ji, Jie Li, Weiqiang Shi, Yu‐Fang Pei, Jiafu Li et al. · 2022 · Frontiers in Cell and Developmental Biology
88. Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
    Mayumi Kobayashi Kato, Yuka Asami, Daisuke Takayanagi, Maiko Matsuda, Yoko Shimada, Kengo Hiranuma, Ikumi Kuno, Masaaki Komatsu, Ryuji Hamamoto, Koji Matsumoto et al. · 2022 · Cancer Science
89. Impact of the new molecular classification of endometrial cancer: A French cohort study
    Jeremie Benichou, Corentin Schwall, Xavier Sastre‐Garau, Julie Méreaux, Grégoire Miailhe, Sofiane Bendifallah, Bassam Haddad, Cyril Touboul, Rana Mitri-Frangieh, Yohann Dabi · 2022 · Gynecologic Oncology
90. Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification
    Florine A. Eggink, Constantijne Helene Mom, Klasiena Bouwman, Dorry Boll, Jeroen Becker, Carien L. Creutzberg, Gerard C. Niemeijer, Willemien J. van Driel, Anna K.L. Reyners, A.G.J. van der Zee et al. · 2017 · European Journal of Cancer
91. Expression of miR‑106 in endometrial carcinoma RL95‑2 cells and effect on proliferation and invasion of cancer cells
    Xingjun Li, Xianghua Yi, Chuanding Bie, Zhemin Wang · 2018 · Oncology Letters
92. The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis
    Daniela Rivera, Michele Paudice, Giulia Accorsi, Floriana Valentino, Marta Ingaliso, Ada Pianezzi, Paola Roggieri, Lucia Trevisan, Giulia Buzzatti, Serafina Mammoliti et al. · 2023 · Journal of Clinical Medicine
93. Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications
    Elisabetta Kuhn, Donatella Gambini, Letterio Runza, Stefano Ferrero, Giovanna Scarfone, Gaetano Bulfamante, A. Ayhan · 2024 · Cancers
94. Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort Study
    Sabrina Paratore, Angela Russo, Giusi Blanco, Katia Lanzafame, Eliana Giurato, Giovanni Bartoloni, Marco D’Asta, Mirella Sapienza, Valeria Solarino, Valentina Vinci et al. · 2025 · Cancers
95. Could Inhibiting the DNA Damage Repair Checkpoint Rescue Immune-Checkpoint-Inhibitor-Resistant Endometrial Cancer?
    Yinuo Li, Xiangyu Wang, Xin Hou, Xiangyi Ma · 2023 · Journal of Clinical Medicine
96. Analysis of patients with endometrial carcinoma using the ProMise classifier: a pilot study from India
    Alka Dahiya, Rajadurai Abarna, Sherin Daniel, Ajit Sebastian, Dhanya Susan Thomas, Vinotha Thomas, Rachel George, Thomas Samuel Ram, Arvind Sathyamurthy, Grace J. Rebekah et al. · 2023 · Archives of Gynecology and Obstetrics
97. Genomic profile of Chinese patients with endometrial carcinoma
    Jin Li, Xiaoqi Li, Chenlian Quan, Xiaoqiu Li, Chong Wan, Xiaohua Wu · 2023 · BMC Cancer
98. Metastases and Recurrence Risk Factors in Endometrial Cancer—The Role of Selected Molecular Changes, Hormonal Factors, Diagnostic Methods and Surgery Procedures
    Anna Markowska, Włodzimierz Baranowski, Kazimierz Pityński, Anita Monika Chudecka-Glaz, Janina Markowska, Włodzimierz Sawicki · 2023 · Cancers
99. Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer
    Khalid Akkour, Ibrahim O. Alanazi, Assim Abdulaziz Alfadda, Afshan Masood, H Alhalal, Salini Scaria Joy, Ali Bassi, Eman Alshehri, Moudi A. Alwehaibi, Maria Arafah et al. · 2024 · BMC Cancer
100. Innovative Follow-up Strategies for Endometrial Cancer
     Anna Collins, Alexandra Taylor, David S. Guttery, Esther Louise Moss · 2021 · Clinical Oncology